A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
Aurora 激酶 A 抑制剂 Alisertib 治疗去势抵抗性和神经内分泌性前列腺癌患者的 II 期试验：疗效和生物标志物
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-18-1912
Himisha Beltran, Clara Oromendia, Daniel C Danila, Bruce Montgomery, Christopher Hoimes, Russell Z Szmulewitz, Ulka Vaishampayan, Andrew J Armstrong, Mark Stein, Jacek Pinski, Juan M Mosquera, Verena Sailer, Rohan Bareja, Alessandro Romanel, Naveen Gumpeni, Andrea Sboner, Etienne Dardenne, Loredana
